Lionbridge’s Top 10 Life Sciences Translation Blogs in 2023

2023年Lionbridge十大生命科学翻译博客

2023-12-26 21:09 lionbridge

本文共634个字,阅读需7分钟

阅读模式 切换至中文

2023 has significantly changed how we approach life sciences translation, patient communications, and the industry in general. We’re cautiously considering how to benefit from generative AI while balancing risk and protecting patients. We’re learning best practices for clinical trial translation under the EU MDR and striving towards more inclusive research focused on patient outcomes. Review our popular 2023 life sciences blogs below. #1 Lessons Learned from the EU Clinical Trials Regulation Lionbridge’s Life Sciences team reviews a year of European Union Clinical Trials Regulation (EU CTR) compliance. We share best practices and learnings from our experience providing life sciences translation services to customers impacted by this relatively new regulation. #2 Generative AI and Life Sciences Discover current and potential use cases for generative AI in the Life Sciences industry. Learn why slow adoption and risk management are crucial to protecting patient safety. #3 Tactics for More Diverse Clinical Trial Recruitment Finding the optimal clinical trial to participate in is a serious challenge for many patients. Further complicating matters, there is a misconception that certain minority groups don’t want to engage in clinical trials. However, they don’t participate because they’re often not offered opportunities. Read the article to learn tactics for recruiting from more diverse pools of patients. #4 Writing Clinical Trial Results for Multi-Regional Clinical Trials Read about the essential steps to writing effective trial results for multi-regional clinical trials. Understand how to reach various audiences, including patients unfamiliar with technical medical terminology. #5 eCOA Providers Case Study Translation and migration projects associated with electronic Clinical Outcome Assessment (eCOA) measures must meet rigorous clinical research standards and timelines. Understand how Lionbridge has assisted customers with handling clinical research’s linguistic and technological requirements. #6 Patient Centricity in Clinical Trials In this blog about clinical trial management, Lionbridge experts consider the challenges inherent with multilingual and multi-regional clinical trials. Uncover more about language compliance requirements, improving patient outcomes, and cutting-edge clinical research language support. #6 Patient Centricity in Clinical Trials In this blog about clinical trial management, Lionbridge experts consider the challenges inherent with multilingual and multi-regional clinical trials. Uncover more about language compliance requirements, improving patient outcomes, and cutting-edge clinical research language support. #7 The Extended Medical Devices Regulation Transition Dive into the extension of the European Union Medical Devices Regulation transition period. Learn why the extension occurred, the complications it will cause, and the implications for medical device manufacturers. #8 MDR Language Requirements and Medical Device Translation Read our blog post about the European Medical Device Regulation (EU MDR) and its implications for device makers. This post will review the MDR’s increased language requirements. These new requirements will both burden device makers and present opportunities. #9 Biopharmaceutical Clinical Labeling Case Study To meet the stringent, rigorous process of clinical labeling, it’s essential to work with reliable, accurate, and efficient life sciences translation services. Read our case study to see how Lionbridge has been helping a global biopharmaceutical company for nearly a decade. We assist in maintaining compliance and meeting tight deadlines while translating label phrases for Investigational Medicinal Product (IMP) labels. #10 Webinar Recap: Life Sciences and Generative AI Generative AI tools may feel futuristic and risky, but Lionbridge has been preparing and exploring how these tools can be applied to our life sciences translation services.  Learn more from Paraic O’Donnell, a Life Sciences industry veteran, about how we apply Generative AI for our Life Sciences clients — and some future use cases. Get in touch Interested in learning more about life sciences and generative AI? Exploring potential generative AI use cases for your organization? We can assist with these areas or your life sciences translation needs. You can rely on our deep experience, knowledge, and innovative technology. Contact us today to find out more about Lionbridge’s life sciences translation solutions.
2023年极大地改变了我们对待生命科学翻译、患者沟通和整个行业的方式。我们正在谨慎地考虑如何从生成式人工智能中受益,同时平衡风险和保护患者。我们正在学习欧盟MDR下临床试验翻译的最佳实践,并努力进行更全面的关注患者结果的研究。 在下面回顾我们广受欢迎的2023年生命科学博客。 #1欧盟临床试验法规的经验教训 Lionbridge的生命科学团队审查了一年的欧盟临床试验法规(欧盟CTR)合规性。我们分享我们为受这一相对较新的法规影响的客户提供生命科学翻译服务的最佳实践和经验教训。 #2生殖人工智能和生命科学 发现生命科学行业中生成式人工智能的当前和潜在用例。了解为什么缓慢采用和风险管理对保护患者安全至关重要。 #3更多样化临床试验招募策略 对于许多患者来说,找到参与的最佳临床试验是一个严峻的挑战。更复杂的是,有一种误解,认为某些少数群体不想从事临床试验。然而,他们不参与,因为他们通常没有机会。阅读这篇文章,学习从更多样化的患者群体中招募的策略。 #4为多区域临床试验撰写临床试验结果 阅读为多区域临床试验撰写有效试验结果的基本步骤。了解如何接触各种受众,包括不熟悉医学技术术语的患者。 #5 eCOA供应商案例研究 与电子临床结果评估(eCOA)措施相关的翻译和迁移项目必须符合严格的临床研究标准和时间表。了解Lionbridge如何帮助客户处理临床研究的语言和技术要求。 #6临床试验以患者为中心 在这篇关于临床试验管理的博客中,Lionbridge专家考虑了多语言和多地区临床试验固有的挑战。了解有关语言合规性要求、改善患者结果和尖端临床研究语言支持的更多信息。 #6临床试验以患者为中心 在这篇关于临床试验管理的博客中,Lionbridge专家考虑了多语言和多地区临床试验固有的挑战。了解有关语言合规性要求、改善患者结果和尖端临床研究语言支持的更多信息。 #7延长医疗器械监管过渡期 深入了解欧盟医疗器械法规过渡期的延长。了解延期的原因、它将导致的并发症以及对医疗器械制造商的影响。 #8 MDR语言要求和医疗器械翻译 阅读我们关于欧洲医疗器械法规(EU MDR)及其对器械制造商的影响的博文。这篇文章将回顾MDR增加的语言要求。这些新要求既会给设备制造商带来负担,也会带来机遇。 #9生物制药临床标识案例研究 为了满足严格的临床标签流程,必须使用可靠、准确和高效的生命科学翻译服务。阅读我们的案例研究,了解Lionbridge近十年来如何帮助一家全球生物制药公司。在翻译研究药品(IMP)标签的标签短语时,我们协助保持合规性并满足紧迫的期限。 #10网上研讨会回顾:生命科学和生殖人工智能 生成式人工智能工具可能感觉超前且有风险,但Lionbridge一直在准备和探索如何将这些工具应用于我们的生命科学翻译服务。从生命科学行业资深人士帕拉伊克·安东内尔那里了解更多关于我们如何为生命科学客户应用生成式人工智能的信息,以及一些未来的用例。 取得联系 有兴趣了解更多关于生命科学和生殖人工智能的知识吗?为您的组织探索潜在的生成式人工智能用例?我们可以在这些领域或您的生命科学翻译需求方面提供帮助。您可以依靠我们丰富的经验、知识和创新技术。请立即联系我们,了解有关Lionbridge生命科学翻译解决方案的更多信息。

以上中文文本为机器翻译,存在不同程度偏差和错误,请理解并参考英文原文阅读。

阅读原文